REG - CVS Group plc - Exercise of Options and Total Voting Rights

CVSAnnouncement

31/03/2022 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220331:nRSe6676Ga&default-theme=true

RNS Number : 6676G  CVS Group plc  31 March 2022

31 March 2022

CVS Group plc

("CVS" or the "Company")

Exercise of Options and Total Voting Rights

CVS, one of the UK's leading providers of integrated veterinary services,
confirms that certain employees have exercised options during March under the
Company's Save As You Earn (SAYE) 2021 scheme (together, the "SAYE Exercise")
totalling 15,887 ordinary shares of 0.2 pence each ("Ordinary Shares").
Admission of the 15,887 new Ordinary Shares has been satisfied via the block
listing for the SAYE 2021 Scheme.

Following the issue of these new Ordinary Shares, which rank pari passu in all
respects with the Company's existing Ordinary Shares, the Company has a total
issued share capital of 71,049,684 Ordinary Shares, each carrying one voting
right. The Company holds no Ordinary Shares in treasury and the total number
of voting rights is therefore 71,049,684.

This figure may be used by shareholders as the denominator for the
calculations by which they will determine if they are required to notify their
interest, or a change to their interest, in the Company under the FCA's
Disclosure Guidance and Transparency Rules.

 

Contacts:

CVS Group Plc
 
                        Tel: +44 1379 644 288

Jenny Farrer, Company Secretary

 

Singer Capital Markets (Nominated Adviser & Broker)
Tel: +44 20 7496 3000

Aubrey Powell/ Jen Boorer /Rachel Hayes

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  TVRBLGDXGUXDGDG